COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 35 filers reported holding COCRYSTAL PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | +100.0% | 5,584 | +296.6% | 0.00% | – |
| Q2 2022 | $1,000 | -90.0% | 1,408 | -92.3% | 0.00% | – |
| Q1 2022 | $10,000 | -56.5% | 18,177 | -48.5% | 0.00% | – |
| Q4 2021 | $23,000 | +76.9% | 35,271 | +194.0% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 11,998 | +17.5% | 0.00% | – |
| Q2 2021 | $13,000 | +62.5% | 10,215 | +67.8% | 0.00% | – |
| Q1 2021 | $8,000 | – | 6,089 | +1680.4% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 342 | -98.0% | 0.00% | – |
| Q2 2020 | $26,000 | +225.0% | 17,337 | +54.8% | 0.00% | – |
| Q1 2020 | $8,000 | – | 11,200 | +11814.9% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 94 | -75.8% | 0.00% | – |
| Q2 2019 | $1,000 | -80.0% | 389 | -79.5% | 0.00% | – |
| Q1 2019 | $5,000 | -50.0% | 1,897 | -54.0% | 0.00% | – |
| Q3 2018 | $10,000 | -33.3% | 4,125 | +58.8% | 0.00% | – |
| Q1 2018 | $15,000 | – | 2,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 6,110,657 | $7,638,000 | 1.08% |
| Altium Capital Management LP | 776,000 | $970,000 | 0.22% |
| Alyeska Investment Group, L.P. | 2,750,100 | $3,438,000 | 0.04% |
| Virtu Financial LLC | 116,625 | $146,000 | 0.01% |
| Parallel Advisors, LLC | 184,708 | $231,000 | 0.01% |
| Renaissance Technologies | 2,593,933 | $3,242,000 | 0.00% |
| CIM, LLC | 11,000 | $12,000 | 0.00% |
| Western Wealth Management, LLC | 19,115 | $24,000 | 0.00% |
| Mariner, LLC | 200,055 | $250,000 | 0.00% |
| BRIGHTON JONES LLC | 36,000 | $45,000 | 0.00% |